STANDARDIZATION OF MODEL OF INDUCTION OF HEPATOTOXICITY WITH ANTI-TUBERCULOSIS DRUGS IN WISTAR ALBINO RATS

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2017, Vol 10, Issue 6

Abstract

Objective: The objective of the study to standardize the model of hepatotoxicity induced by ATT drugs in Wistar Albino rats. Isoniazid (INH), rifampicin (RMP), pyrazinamide (PZA), the first line drugs used in the treatment of tuberculosis (TB) associated with the potential adverse effect. Numerous animal studies were reported endeavoring induction and cure of anti-TB (ATT) drug-induced hepatotoxicity using herbal and chemical drugs. However, the previous reported study failed to replicate where Wistar albino rats were treated with INH, RMP, and PZA and had shown the significant development of liver injury. Hence in present paper, aimed to develop a standardize model of induction of hepatotoxicity with ATT drugs.Methods: Wistar rats were treated with ATT drugs in combination in various doses up to 4-8 weeks. Total nine experiments were conducted to achieve successful hepatotoxicity. The aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were the biochemical parameters of assessment. Histopathological changes in the liver were also examined.Results: No evidence of any liver injury or an inflammatory infiltrate has been observed as had been reported in the previous studies. Rather decrease in serum ALT levels has been observed by researcher. In short, hepatic injury cannot be developed with the doses used in previous reported papers. The successful attempt to induce hepatotoxicity can be achieved with the doses of INH - 100, RMP - 300, PZA - 700 mg/kg. The findings were confirmed by the raised ALT, AST, and ALP levels compared with baseline. The histopathological changes also support the findings.Conclusion: The dose of INH - 100, RMP – 300 and PZM - 700 mg/kg. Succeeds to induce hepatotoxicity in Wistar albino rats and Swiss albino mice as well.

Authors and Affiliations

Sarita M Kapgate, Abhijit B Patil

Keywords

Related Articles

INHIBITION ACTIVITY OF WATER HYACINTH LEAF EXTRACT (EICHHORNIA CRASSIPES) AGAINST AGGREGATIBACTER ACTINOMYCETEMCOMITANS

Objective: Water hyacinth (Eichhornia crassipes) contains bioactive compounds that have antibacterial properties. The antibacterial agent is required in the treatment of periodontitis. The aim of this study was to determ...

BERBERINE HYDROCHLORIDE COULD PROVE TO BE A PROMISING BULLET AGAINST CLOSTRIDIUM DIFFICILE INFECTION: A PRELIMINARY STUDY FROM SOUTH INDIA

Objective: Recurrent Clostridium difficile infection (CDI) and the emergence of strains with reduced susceptibility to metronidazole and vancomycinwarrants alternative therapy. Hence, we tested the potential efficacy of...

TARGETING THE TARGET USING NANOPARTICLES - A REVIEW

  The challenge of drug delivery is the liberation of drug agents at the right time in a safe and reproducible manner, usually to a specific target site. Conventional dosage forms, such as orally administered pills and...

RATE OF MALIGNANT BREAST CANCER AMONG WOMEN WITH BREAST MASS ATTENDING ALDEWANIYAH TEACHING HOSPITALS: A CROSS-SECTIONAL STUDY

Objective: The problems of breast mass, pain, or discharge are extremely common in the Iraqi population, as well as, globally. However, the trend in most health-care institutions is that most breast lesions are of benign...

PROSOPIS CINERARIA LEAF EXTRACT PROTECT H2O2 INDUCED OXIDATIVE STRESS-INDUCED CELL DEATH IN SACCHAROMYCES CEREVISIAE

 Objective: Saccharomyces cerevisiae cells exposed to oxidant damage were used as in vitro model to assess the cytotoxic effect and apoptotic eventsin the presence and absence of the methanolic leaf extract of Prosopis...

Download PDF file
  • EP ID EP605320
  • DOI 10.22159/ajpcr.2017.v10i6.11971
  • Views 128
  • Downloads 0

How To Cite

Sarita M Kapgate, Abhijit B Patil (2017). STANDARDIZATION OF MODEL OF INDUCTION OF HEPATOTOXICITY WITH ANTI-TUBERCULOSIS DRUGS IN WISTAR ALBINO RATS. Asian Journal of Pharamceutical and Clinical Research, 10(6), 150-153. https://www.europub.co.uk/articles/-A-605320